GenePrint(R) 24 System, 400rxn Kits

GenePrint(R)

24 System, 400rxn Kits Product Service Code:

6550 NAICS Code:

325413 Place of Performance: National Institutes of Health Clinical Center 10 Center Drive Bethesda, MD 20892 POTS: 25-002231 Description This is a notice of intent, not a request for a quotation. A solicitation document will not be issued, and quotations will not be requested.

The National Institutes of Health, Office of Purchasing and Contracts, on behalf of the Department of Laboratory Medicine, Hematology Service, intends to issue a firm-fixed price Purchase Order to Promega Corporation, located at 2800 Woods Hollow Rd, Fitchburg, Wisconsin 53711-5300. The order will cover a six (6) month base year, with two (2) additional twelve (12) month option years, for the GenePrint® 24 System, 400rxn Kits (Product Code: B1874).

Period of Performance: 03/01/2025-09/30/2027. The Department of Laboratory Medicine, Hematology Service, conducts engraftment monitoring Chimerism Testing in the clinical laboratory for patients who have undergone allogeneic transplants. The GenePrint® 24 System kits are utilized to amplify Short Tandem Repeats (STR) for monitoring the engraftment chimerism of donor pluripotent cells in bone marrow and stem cell transplant patients.

The GenePrint® 24 System, 400rxn Kits are the only kits that have been fully validated for this use and can generate the required number of loci for the protocol. Promega Corporation is the sole manufacturer and supplier of these proprietary kits. Without the GenePrint® 24 System, 400rxn kits, patient treatment and care would be negatively impacted.

This acquisition is being conducted using policies unique to the Federal Acquisition Regulation 13.501 Special documentation requirements for sole source acquisitions exceeding the Simplified Acquisition Threshold.

Interested Parties: Interested parties capable of providing the same or similar products or services described in this notice may submit a capability statement outlining their capability to perform the described work. Capability Statements must be received within the time set forth in this synopsis to be considered by the Government. The determination to compete this proposed contract based on responses to this notice is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement.

Comments: Comments to this announcement, referencing this posting number on the email subject line, may be submitted to the CC, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, electronically to the attention of Tasha Lowe Contract Specialist, lowet2@mail.nih.gov by the due date February 20, 2025, (3pm EST) and time marked in this notice.